Filing Details
- Accession Number:
- 0001209191-17-066810
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-21 16:43:15
- Reporting Period:
- 2017-12-21
- Accepted Time:
- 2017-12-21 16:43:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1328143 | Adamas Pharmaceuticals Inc | ADMS | Pharmaceutical Preparations (2834) | 421560076 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1568249 | J Jennifer Rhodes | C/O Adamas Pharmaceuticals, Inc. 1900 Powell St., Suite 750 Emeryville CA 94608 | Cbo, Gc & Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-12-21 | 440 | $32.30 | 28,860 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units.
- Includes 845 shares purchased on 11/30/17 through the issuer's employee stock purchase plan.
Billionaire Hedge Funds
